GlassScriptPhysician profile
Jeffrey B Garris
NPI 1295842029
$10,982.64
in general payments reported to CMS, 2019-2025
22 companies · $457 in 2025
The $457 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,146 · 2020: $1,137 · 2021: $2,652 · 2022: $3,437 · 2023: $870 · 2024: $284 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277 · Travel and Lodging: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.86 |
| Travel and Lodging | $333.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,602.09 | 2021-2024 | Axonics |
| Medtronic, INC. | $1,557.42 | 2021-2025 | Altaviva, Interstim |
| Intuitive Surgical, INC. | $1,350.77 | 2019-2022 | |
| Medtronic USA, INC. | $1,316.55 | 2019-2020 | |
| Abbvie INC. | $561.18 | 2019-2023 | |
| Coloplast Corp | $360.22 | 2019-2023 | Altis |
| Astellas Pharma US INC | $226.24 | 2019-2023 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $204.48 | 2020-2025 | Axonics, Solyx Sis System |
| Femselect INC. | $174.28 | 2023 | Enplace |
| Caldera Medical, INC | $162.02 | 2023 | Desara |
| Pfizer INC. | $120.31 | 2019-2023 | |
| Coopersurgical, INC. | $63.41 | 2019-2023 | Endosee |
| Therapeuticsmd, INC. | $42.87 | 2019-2020 | |
| Conmed Corporation | $41.67 | 2019 | |
| Laborie Medical Technologies Corp. | $41.65 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $36.00 | 2019-2020 | |
| Smith+Nephew, INC. | $33.37 | 2019 | |
| Ethicon US, LLC | $28.54 | 2022 | |
| Osiris Therapeutics INC. | $20.70 | 2019 | |
| Convatec INC. | $14.62 | 2025 | |
| Urovant Sciences INC | $12.71 | 2022 | |
| Mission Pharmacal Company | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Garris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.